Evidence suggests that intestinal epithelial cells express receptors that recognize FGF19, such as FGFR4 and β-Klotho, and cultured mouse enteroids respond to FGF19 treatment 38 and inhibition of FGF19 reduced growth and metastasis of colon tumor grafts 39, 40. This evidence concerns the gene KLB and colonic neoplasm.